Preclinical News and Research

RSS
Champions enters exclusive license agreement with BCCA for Irinophore C

Champions enters exclusive license agreement with BCCA for Irinophore C

Results of Boehringer Ingelheim's BI 201335 study presented at Annual Meeting of EASL

Results of Boehringer Ingelheim's BI 201335 study presented at Annual Meeting of EASL

Neogenix Oncology to present laboratory studies of NEO-101 at AACR Annual Meeting

Neogenix Oncology to present laboratory studies of NEO-101 at AACR Annual Meeting

Study shows immune therapy can prevent pregnancy in mammals including humans

Study shows immune therapy can prevent pregnancy in mammals including humans

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

Immune therapy can control fertility in mammals

Immune therapy can control fertility in mammals

RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals to acquire Apthera

Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

Molecular Templates ETB preclinical data against cancer to be presented at AACR meeting

Researchers identify drug candidate that can treat prostate cancer

Researchers identify drug candidate that can treat prostate cancer

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

Rexahn's RX-5902 pre-clinical data against cancer to be presented at AACR Annual Meeting

Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

FDA grants orphan drug status to America Stem Cell's ASC-101

FDA grants orphan drug status to America Stem Cell's ASC-101

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Pathfinder cell-based therapy reverses diabetes in mouse model

Pathfinder cell-based therapy reverses diabetes in mouse model

Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy

Concert initiates CTP-499 Phase 1 study in patients with diabetic nephropathy

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

CytRx to present bafetinib preclinical study results at AACR Annual Meeting

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting

AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.